RESEARCH TRIANGLE PARK, N.C., April 07, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (“Opus” or the “Company”) (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene ...
Opus East LLC and Opus West Corp., two of the five independent operating companies of the Opus Group, have filed for bankruptcy protection to help liquidate their portfolios, according to parent ...
Board Comments on Misguided Campaign from Mina Sooch to Replace a Majority of Opus’ Directors and Promote a Flawed Strategy Urges Stockholders to Vote on the BLUE Proxy Card FOR All Nine of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results